Marimed (MRMD) Equity Income (2019)

Marimed (MRMD) reported Equity Income of $928000.0 for Q3 2019, up 364.0% quarter-over-quarter from $200000.0 in Q2 2019.

Marimed (MRMD) Equity Income (2019) Analysis & Trends

Marimed (MRMD) has 1 years of Equity Income data on file, last reported at $928000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Income (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-1.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	25.30 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-9.68 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	14.91 Mn
10	Marimed	-	-	15.28 Mn	-

Download Data